InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Wolf Myles, Director. Director active across 1 companies, notably Akebia Therapeutics, Inc.. Cumulatively, 3 reports have been logged. The latest transaction was disclosed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
013,700 shares0
Common Stock
SEC:0001562180-22-004978:0·
013,700 shares0
Common Stock
SEC:0001562180-21-004031·
013,700 shares0
Common Stock
SEC:0001562180-21-004031:0·
3 of 3 declarations
About Wolf Myles
Myles Wolf is a Board Member at Akebia Therapeutics, Inc. He contributes to the governance of the company by participating in strategic decisions and providing his expertise to the board.
